A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Novartis
Novartis
Zhejiang Provincial People's Hospital
Seagen Inc.
Ascentage Pharma Group Inc.
Hospices Civils de Lyon
Stanford University
Sandoz
Valerio Therapeutics